<DOC>
	<DOCNO>NCT01946048</DOCNO>
	<brief_summary>The aim present study investigate safety efficacy intramyocardial implantation allogeneic mesenchymal stem cell patient ischemic cardiomyopathy .</brief_summary>
	<brief_title>Umbilical Cord Derived Mesenchymal Stem Cells Therapy Ischemic Cardiomyopathy</brief_title>
	<detailed_description>Coronary artery disease ( CAD ) common disorder lead heart failure . Not people CAD eligible today 's standard treatment . One new treatment approach use umbilical cord blood derive mesenchymal stem cells—specialized cell capable develop type cells—to stimulate growth new blood vessel heart . The aim present study investigate safety efficacy intramyocardial implantation allogeneic mesenchymal stem cell patient ischemic cardiomyopathy .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>1 . Age 30 80 year 2. ischemic cardiomyopathy 3 . Left ventricular infarction area seriously low movement movement 4 . The low whole leave ventricular systolic function ( LVEF 45 % less ) 5 . Have line quasi coronary interventional treatment 6 . Willing accept patient followup evaluation 7 . Have sign inform consent form approve ethic committee 1 . Non elevation Swave Twave patient acute myocardial infarction 2 . No function damage patient acute myocardial infarction 3 . Acute myocardial infarction complicate leave ventricular aneurysm intend surgery 4 . Complications acute myocardial infarction machine ( include : ventricular septal perforation , papillary muscle rupture , etc . ) 5 . Acute infectious disease 6 . Blood system diseases , thrombocytopenia , severe anemia , leukemia , etc 7 . Severe renal disease , creatinine clearance &lt; 36 ml/min , serum creatinine &gt; 265 umol/L 8 . Laboratory test suggest abnormal liver function , glutamatepyruvate transaminase ( ALT ) &gt; 4 time upper limit normal 9 . Unstable cerebral lesion 10. malignant tumor 11 . Cognitive dysfunction dementia patient , patient severe mental illness 12 . Patients severe physical disability ca n't regular followup 13 . Other serious uncontrolled system disease 14 . To prepare pregnancy woman patient 15 . Have percutaneous coronary intervention contraindication : highrisk patient , digestive tract , intracranial hemorrhage contrast allergy 16 . Can use test dose atorvastatin 17 . Is complete accordance requirement test time magnetic resonance imaging ( MRI ) , PET , SPECT , followup testing ( e.g. , patient implant pacemaker artificial joint ) 18 . Patients unable unwilling sign consent form</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>